DGAT-1 inhibitors (Pfizer/Bristol-Myers Squibb)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameDGAT-1 inhibitors (Pfizer/Bristol-Myers Squibb)
Drug Alias Namediacylglycerol acyltransferase inhibitors (Pfizer/BMS)DGAT-1 inhibitors (Bayer)PF-046220110PF-04094667
ClassificationSmall molecules
Mechanisms of ActionDiacylglycerol O-acyltransferase 1 inhibitors
TargetsDiacylglycerol O-acyltransferase 1
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesWestern Europe
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer IncBayer AGBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsMetabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A